Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Hydroxychloroquine Sulphate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 130Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    31/10/2025 Fermion Oy
    Finland
    		 Fermion Oy 305MF10090 Hydroxychloroquine sulfate 2023-08-02 2023-08-02 Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland
    31/10/2025 Chongqing Kangle Pharmaceutical
    China
    		 CHONGQING KANGLE PHARMACEUTICAL CO. , LTD. 305MF10077 Hydroxychloroquine Sulfate 2023-07-05 2023-07-05 No. 4 HUAZHONG ROAD, CHONGQING (CHANGSHOU) CHEMICAL INDUSTRIAL PARK